Work

Notable clinical activity of immune checkpoint inhibitors with or without brentuximab vedotin in relapsed or refractory gray zone lymphoma

Year: 2026

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2026.301128

Authors: Ivan Dlouhy, Tiago Maia, Diana Viegas, Nina Abreu, José Cabeçadas, Maria Gomes Da Silva

Institution: Instituto Português de Oncologia Francisco Gentil

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: Eli Lilly and Company, AstraZeneca, Gilead Sciences, Ministério da Educação

OpenAlex ID: W7168521364

FWCI:

Cites:

Cited by:

Related to: